Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Search Results (61)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma.Academic Article Why?
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses.Academic Article Why?
Advances in CAR T-Cell Therapy for Aggressive B-NHL.Academic Article Why?
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.Academic Article Why?
CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy.Academic Article Why?
Current Status of CAR T Cell Therapy for Leukemias.Academic Article Why?
Kline, Justin P.Person Why?
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy.Academic Article Why?
Riedell, PeterPerson Why?
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.Academic Article Why?
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.Academic Article Why?
Ventricular fibrillation following autologous intramyocardial cell therapy for inherited cardiomyopathy.Academic Article Why?
Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy.Academic Article Why?
Bishop, Michael R.Person Why?
Nakamura, YusukePerson Why?
Per Page    Page  of 5last Nextnext
Prev
Search Criteria
  • CAR
  • T
  • cell therapy
Filter by Type